Abstract

BackgroundResistance to chemotherapy is a major obstacle in the effective treatment of cancer patients. B7-homolog 1, also known as programmed death ligand-1 (PD-L1), is an immunoregulatory protein that is overexpressed...

Highlights

  • Resistance to chemotherapy is a major obstacle in the effective treatment of cancer patients

  • B7-homolog 1 (B7-H1) protein is detectable by immunohistochemistry in esophageal adenocarcinoma biopsies We have shown that B7-H1 expression can be induced in a 5-FU dose dependent manner in OE33 cells

  • We have demonstrated that while B7-H1 expression is low at baseline its expression can be induced in HCT 116 p53+/+, HCT 116 p53−/− and OE33 cells following treatment with 5-FU, the chemotherapy of choice for both advanced colorectal cancer (CRC) and esophageal adenocarcinoma (EAC)

Read more

Summary

Introduction

Resistance to chemotherapy is a major obstacle in the effective treatment of cancer patients. B7-homolog 1, known as programmed death ligand-1 (PD-L1), is an immunoregulatory protein that is overexpressed in several human cancers. Methods: HCT 116 p53+/+, HCT 116 p53−/− colorectal cancer (CRC) and OE33 esophageal adenocarcinoma (EAC) cells were treated with increasing doses of 5-FU (0.5 uM, 5 uM, 50 uM, 500 uM) or interferon gamma (IFN-γ, 10 ng/ mL) in culture for 24 h and B7-H1 expression was quantified using flow cytometry and western blot analysis. Results: B7-H1 expression in human HCT 116 p53+/+ and HCT 116 p53−/− CRC cells lines, while low at baseline, can be induced by treatment with 5-FU. OE33 baseline B7-H1 expression exceeded CRC cell maximal expression and could be further increased in a dose dependent manner following 5-FU treatment in the absence of immune cells. While B7-H1 expression was not enhanced in post-treatment esophagectomy specimens, this may be due to the limits of immunohistochemical quantification

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call